
Clinical Research
Basic Research
Articles
Genomic Project

Articles

Morphologic and functional imaging of malignant pleural mesothelioma (Eur J Radiol 2007)

Preclinical studies of the proteasome inhibitor bortezomib in malignant pleural mesothelioma (Cancer Chemother Pharmacol 2007)

Expression patterns of inhibitor of apoptosis proteins in malignant pleural mesothelioma (J Pathol 2007)

Macroscopic complete resection: the goal of primary surgery in multimodality therapy for pleural mesothelioma (J Thorac Oncol 2006)

Phase I to II study of pleurectomy/decortication and intraoperative, intracavitary, hyperthermic cisplatin lavage for mesothelioma - J Clin Oncol (2006)

Functional Analysis of c-Met/Hepatocyte Growth Factor Pathway in Malignant Pleural Mesothelioma - Cancer Research (2006)

Multimodality treatments in the management of malignant pleural mesothelioma: an update - Hemotol Oncol Clin North Amer (2005)

Inhibition of the Met Receptor in Mesothelioma - Clin Cancer Res (2005)

Open-Label study of pemetrexed alone or in combination with Cisplatin for the treatment of patients with peritoneal mesothelioma: outcomes of an expanded access program - Clin Lung Cancer (2005)

Therapeutic targeting of multiple signaling pathways in malignant pleural mesothelioma - Oncology (2005)

Localized Malignant Mesothelioma - Am J Surg Path (2005)

Transcriptional profiling of mesothelioma using microarrays - Lung Cancer (2005)

Identification of novel candidate oncogenes and tumor suppressors in malignant pleural mesothelioma using large-scale transcriptional profiling - Am J Pathol (2005)

Validation of genomics-based prognostic tests in malignant pleural mesothelioma - Clin Cancer Research (2005)

Cardiac sarcoma 14 years after treatment for pleural mesothelioma - N Engl J Med. (2005)

Innovative therapies: intraoperative intracavitary chemotherapy-Thorac Surg Clin. (2004)

Extrapleural pneumonectomy for diffuse malignant pleural mesothelioma: techniques and complications- Thorac Surg Clin. (2004)

Malignant pleural mesothelioma: overview of the North American and European experience-Thorac Surg Clin. (2004)

Role of Asbestos in etiology of malignant pleural mesothelioma - Thorac Surg Clin (2004)

Pleural biopsy: a reliable method for determining the diagnosis but not subtype in mesothelioma - Ann Thorac Surg. (2004)

Prevention, early detection, and management of complications after 328 consecutive extrapleural pneumonectomies - J Thorac Cardiovasc Surg. (2004)

Patterns of failure following surgical resection for malignant pleural mesothelioma - Thorac Surg Clin. (2004)

Genetics of malignant pleural mesothelioma: molecular markers and biologic targets - Thorac Surg Clin. (2004)

Integrin dependent protein tyrosine phosphorylation is a key regulatory event in collagen IV mediated adhesion and proliferation of human lung tumor cell line, Calu-1 - Ann Thorac Surg. (2004)

Pathology of mesothelioma - Thorac Surg Clin. (2004)

Gene expression profiles predict survival and progression of pleural mesothelioma – Clin Cancer Res (2004)

External beam radiation therapy for the treatment of pleural mesothelioma - Thorac Surg Clin. (2004)

Preoperative assessment and therapeutic options for patients with malignant pleural mesothelioma - Thorac Surg Clin. (2004)

Role of asbestos in etiology of malignant pleural mesothelioma - Thorac Surg Clin. (2004)

Epidemiology, biologic behavior, and natural history of mesothelioma - Thorac Surg Clin.(2004)

Pleural biopsy: a reliable method for determining the diagnosis but not subtype in mesothelioma. Ann Thorac Surg. (2004)

Metabolic Significance of the pattern, intensity and kinetics of (18)F-FDG uptake in malignant pleural mesothelioma – Thorax (2003)

Chemotherapy for malignant pleural mesothelioma – Clin Lung Cancer (2003)

Editorial: 18-FDG imaging of malignant pleural mesothelioma: scientiam impendere vero em leader-Nucl Med Commun (2003)

Using Gene Expression Ratios to Predict Outcome Among Patients with mesothelioma – J Natl Cancer Inst (2003)

Translation of Microarray Data Into Clinically Relevant Cancer Diagnostic Tests Using Gene Expression Ratios in Lung Cancer and Mesothelioma – Cancer Research (2002)

Assessment of Malignant pleural mesothelioma with (18)F-FDG dual-head gamma-camera coincidence imaging: comparison with histopathology – J Nuc Med (2002)

Inhibitor of apoptosis protein-1 promotes tumor cell survival in mesothelioma – Carcinogenesis (2002)

Current surgical management of malignant pleural mesothelioma – Curr Oncol Rep (2002)

Detection and quantification of SV40 large T-antigen DNA in mesothelioma tissues and cell lines – Oncology Reports (2002)

Multimodality treatment of diffuse malignant pleural mesothelioma – Semin Oncol (2002)

Inhibition of epidermal growth factor receptor signaling in malignant pleural mesothelioma – Cancer Res (2002)

Alterations of the p16INK4 locus in human malignant mesothelial tumors – Carcinogenesis (2002)

Diffuse malignant mesothelioma of the pleural space and its management – Oncology (Huntingt) (2002)

Malignant pleural mesothelioma – Cancer Treat Res (2001)

Treatment of malignant mesothelioma – World J Surg (2001)

The International SV40 Working Group: A multicenter evaluation of assays for detection of SV40 DNA and results in masked mesothelioma specimens – Cancer Epidemiol Biomarkers Prev (2001)

The a-folate receptor is highly activated in malignant pleural mesothelioma – J Thorac Cardiovasc surg (2001)

Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients – J Thorac Cardiovasc Surg (1999)

Pleuropneumonectomy in the Treatment of Malignant Pleural Mesothelioma – Chest (1999)

Multimodality management of malignant pleural mesothelioma – Chest (1998)

Visit Pubmed and type in "malignant pleural mesothelioma" to access the most current journal articles on mesothelioma.